Chaim Putterman

Articles in Scholarly Journals [Incomplete List]

  1. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance
    Arthritis & Rheumatism, vol. 56, no. 3, pp. 949–959, 2007
  2. Association of a-actinin–binding anti–double-stranded DNA antibodies with lupus nephritis
    Arthritis & Rheumatism, vol. 54, no. 8, pp. 2523–2532, 2006
  3. Nephritogenic Anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells
    Arthritis & Rheumatism, vol. 54, no. 7, pp. 2198–2210, 2006
  4. Reversible Posterior Leukoencephalopathy in Connective Tissue Diseases
    Seminars in Arthritis and Rheumatism, vol. 35, no. 6, pp. 388–395, 2006
  5. Urinary TWEAK and the activity of lupus nephritis
    Journal of Autoimmunity, vol. 27, no. 4, pp. 242–250, 2006
  6. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays
    Journal of Clinical Investigation, vol. 116, no. 2, pp. 548–548, 2006
  7. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus
    Arthritis & Rheumatism, vol. 52, no. 7, pp. 2080–2091, 2005
  8. Cross-reactivity of human lupus anti-DNA antibodies with ?-actinin and nephritogenic potential
    Arthritis & Rheumatism, vol. 52, no. 2, pp. 522–530, 2005
  9. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies
    Journal of Immunological Methods, vol. 296, no. 1-2, pp. 83–93, 2005
  10. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays
    Journal of Clinical Investigation, vol. 115, no. 12, pp. 3428–3439, 2005
  11. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus
    Autoimmunity Reviews, vol. 3, no. 7-8, pp. 505–509, 2004
  12. Is ?-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Arthritis & Rheumatism, vol. 50, no. 3, pp. 866–870, 2004
  13. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus
    Autoimmunity Reviews, vol. 3, no. 2, pp. 7–11, 2004
  14. The role of TWEAK/Fn14 IN the pathogenesis of inflammation and systemic autoimmunity
    Frontiers in Bioscience, vol. 9, no. 1-3, p. 2273, 2004
  15. B-cell biology
    Rheumatic Disease Clinics of North America, vol. 30, no. 1, pp. 159–174, 2004
  16. Differential effects of interleukin-4 in peptide induced autoimmunity
    Clinical Immunology, vol. 108, no. 2, pp. 80–88, 2003
  17. Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies
    Lupus, vol. 11, no. 12, pp. 865–871, 2002
  18. Arthritis Research, vol. 3, no. 4, p. 197, 2001
  19. Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis
    Arthritis & Rheumatism, vol. 44, no. 7, pp. 1713–1715, 2001
  20. Immunization with a Peptide Surrogate for Double-stranded DNA (dsDNA) Induces Autoantibody Production and Renal Immunoglobulin Deposition
    Journal of Experimental Medicine, vol. 188, no. 1, pp. 29–38, 1998
  21. Down-regulation of surface antigens recognized by systemic lupus erythematosus antibodies on embryonal cells following differentiation and exposure to corticosteroids
    European Journal of Immunology, vol. 28, no. 5, pp. 1656–1662, 1998
  22. Peptide inhibition of glomerular deposition of an anti-DNA antibody
    Proceedings of the National Academy of Sciences, vol. 94, no. 5, pp. 1955–1960, 1997
  23. Studies on the Structure, Regulation, and Pathogenic Potential of Anti-dsDNA Antibodies
    Methods, vol. 11, no. 1, pp. 70–78, 1997
  24. Clinical Problem-Solving: Hypereosinophilic Syndrome
    New England Journal of Medicine, vol. 334, no. 8, pp. 538–540, 1996
  25. Case Series: Hyponatremia Associated With Moderate Exercise
    The American Journal of the Medical Sciences, vol. 311, no. 2, pp. 86–91, 1996
  26. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease
    Proceedings of the National Academy of Sciences, vol. 93, no. 5, pp. 2019–2024, 1996
  27. Testing, Testing, Testing . . .
    New England Journal of Medicine, vol. 333, no. 18, pp. 1208–1211, 1995
  28. Clinical Problem-Solving: Still Hazy after All These Years
    New England Journal of Medicine, vol. 332, no. 5, pp. 332–333, 1995
  29. Still Hazy after All These Years
    New England Journal of Medicine, vol. 331, no. 14, pp. 934–938, 1994
  30. Reactive arthritis associated with Clostridium difficile pseudomembranous colitis
    Seminars in Arthritis and Rheumatism, vol. 22, no. 6, pp. 420–426, 1993
  31. Treatment of the hematological manifestations of dyskeratosis congenita
    Annals of Hematology, vol. 66, no. 4, pp. 209–212, 1993
  32. Embryonal germ-layer antigens: target for autoimmunity
    The Lancet, vol. 339, no. 8799, pp. 975–978, 1992
  33. Recurrent venous thrombosis as the presenting sign of two primary lung carcinomas - 15 years apart
    Respiratory Medicine, vol. 86, no. 6, pp. 521–523, 1992
  34. Colchicine intoxication: Clinical pharmacology, risk factors, features, and management
    Seminars in Arthritis and Rheumatism, vol. 21, no. 3, pp. 143–155, 1991
  35. Use of corticosteroids in the adult respiratory distress syndrome: A clinical review
    Journal of Critical Care, vol. 5, no. 4, pp. 241–251, 1990
  36. Central venous catheter related sepsis: a clinical review
    Resuscitation, vol. 20, no. 1, pp. 1–16, 1990
  37. Modern approaches to the therapy of septic shock
    The American Journal of Emergency Medicine, vol. 8, no. 2, pp. 152–161, 1990
  38. "Treating through" hypersensitivity to co-trimoxazole in AIDS patients
    The Lancet, vol. 336, no. 8706, p. 52, 1990
  39. Sudden cardiac arrest in Israel
    The American Journal of Emergency Medicine, vol. 7, no. 3, pp. 346–347, 1989
  40. The Swan-Ganz Catheter: A decade of hemodynamic monitoring
    Journal of Critical Care, vol. 4, no. 2, pp. 127–146, 1989
  41. Adult respiratory distress syndrome: Current concepts
    Resuscitation, vol. 16, no. 2, pp. 91–105, 1988
  42. Naloxone in circulatory shock
    Klinische Wochenschrift, vol. 65, no. 19, pp. 926–926, 1987
  43. Early use of naloxone in shock — A clinical trial
    Resuscitation, vol. 13, no. 3, pp. 185–190, 1986